The company NuNerve was seeded by a multi-million dollar bequest from Mr Peter Goodenough, a determined and independent entrepreneur, who lost his life to Motor Neuron Disease (MND) in 2004.

The charter of the company in the words of Mr Goodenough is “to destroy Motor Neuron Disease” even though he knew he would not personally benefit from the philanthropic capital invested towards MND research.

NuNerve funds a number of MND research programs in the Queensland Brain Institute (QBI) at The University of Queensland.